Jiangsu Hengrui Pharmaceuticals Co., Ltd.
600276 · Shanghai Stock Exchange (SSE) · Pharmaceuticals
Acerca de la empresa
Jiangsu Hengrui Pharmaceuticals is one of China's largest innovative pharmaceutical companies, with a major focus on oncology, anaesthesia, contrast agents, and metabolic disease therapeutics, and an extensive pipeline of novel small molecules and biologics in clinical development. The company has been investing heavily in drug innovation and has received approvals for several products in regulated international markets including the US and Europe. It is a privately controlled company headquartered in Lianyungang, Jiangsu Province.
| Bolsa | Shanghai Stock Exchange (SSE) |
| Símbolo bursátil | 600276 |
| Sector | Pharmaceuticals |
| Capitalización bursátil orientativa USD | $25.00B |
| Sitio web | Visitar sitio web |
Cotización en tiempo real
Cargando precio en tiempo real…
| Capitalización bursátil | |
| Rango diario | |
| Rango 52 semanas |
Dónde comprar
En su mercado local (Shanghai Stock Exchange (SSE)), es accesible a través de brókers globales que ofrecen dicha bolsa:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Shanghai Stock Exchange — cotización oficial en bolsa
Solo información sobre disponibilidad — no constituye recomendación ni oferta de compra. Confirme elegibilidad, comisiones y disponibilidad vigente con su bróker.
Otras empresas en China
Los datos de la empresa y cualquier precio en tiempo real son orientativos, pueden estar retrasados o ser inexactos, y son exclusivamente para investigación — no constituyen asesoramiento de inversión. Verifique con la bolsa, los registros de la empresa y su bróker.